A New Way to See Inside Tumors and Injured Lungs
Official title: Preclinical Electron Paramagnetic Resonance Tumor Imager
Funded at University of Denver (Colorado Seminary) · NIH-11111354 · Data updated 2026-11-12
This project is creating a new imaging device to help us better understand cancer and lung injuries by looking at important chemical signals in the body.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Denver (Colorado Seminary) NIH-funded |
| Lab location | 1 site (Denver, United States) |
| Project start | July 8, 2021 |
| Project end | June 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $532,723 |
| NIH project number | 5R01CA262159-05 |
| Project ID | NIH-11111354 on NIH RePORTER |
Who could benefit from this research
✓Could help
This preclinical work is not for direct patient participation but aims to benefit future patients with cancer, acute lung injury, stroke, heart attacks, or brain injuries.
✕Less likely to help
Patients whose conditions are not related to the chemical processes studied by this imaging technique may not directly benefit from this specific research.
What this research studies
We are developing a compact and portable imaging system that uses a special technique called electron paramagnetic resonance (EPR). This new system will allow scientists to see how oxygen levels, acidity, and other chemical conditions change within tumors and injured tissues. By understanding these conditions, we hope to find better ways to target cancer with treatments like radiation and chemotherapy. This technology could also help us monitor how well treatments are working and improve care for conditions like stroke, heart attacks, and brain injuries.
Why it matters
Potential benefit: If successful, this new imaging tool could lead to more effective and personalized treatments for cancer and other serious conditions by providing a clearer picture of what's happening inside the body.
How similar studies have gone: This project uses revolutionary methods that make previously impossible studies feasible, suggesting a novel approach.
Where this research is happening
-
University of Denver (Colorado Seminary)
Denver, United States Active
Researchers
- Principal investigator: Eaton, Gareth R — University of Denver (Colorado Seminary)
- Study coordinator: Eaton, Gareth R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.